This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Moritaka Goto: Innovator in Diabetes Treatment
Introduction
Moritaka Goto is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of diabetes. His innovative approach focuses on improving the efficacy of diabetic medications.
Latest Patents
Moritaka Goto holds a patent for a medicine that consists of the concomitant use or combination of a DPP-IV inhibitor and other diabetic medicines. The problem addressed by this invention is to provide a medicine that is effective in treating type 2 diabetes, diabetic complications, or impaired glucose tolerance. The invention is characterized by a compound represented by a specific general formula, along with at least one other diabetic medicine.
Career Highlights
Moritaka Goto is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been instrumental in advancing research and development in diabetes treatment. His work has led to innovative solutions that enhance patient care and medication effectiveness.
Collaborations
Moritaka has collaborated with notable colleagues, including Satoko Yamashita and Keizo Nakaya. Their combined expertise has contributed to the success of various projects within the company.
Conclusion
Moritaka Goto's contributions to diabetes treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to impact the lives of those affected by diabetes, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile